Consolidation in the CRO/CMO/CDMO industry continues. The buyer is Pamplona Capital Management, a global private-equity firm. The nominal deal value is $4.6B.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”